[The study of two immunological markers in patients with type-1 diabetes and in their first degree relatives]. 2004

Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi, Facultatea de Medicină, Disciplina Medicină Generală/Medicină de Familie--copii.

The prediction of diabetes mellitus is mostly based on the existence of plasma markers. The aim of this preliminary study was to determine islet cell antibodies (ICA) and glutamic acid decarboxylase antibodies (GADA) in 28 diabetic children (12 of them having an evolutive disease of 1 year and 16 at the beginning of the diabetes) and to 47 of their first-degree relatives. There have been determined the levels of these two autoantibodies using the ELISA technique. RESULTS To 17 of the patients with type I diabetes have been found high levels of GADA (60.7%) while 8 cases have positive ICA (28.5%). For the patients whose disease was diagnosed 1 year ago there have been found differences between the patients with and without antibodies regarding the level of the average values of Hb A1c, the daily insulin needs and the remission period. From the tested parents (a total of 25), 7 was GADA positive (28%), 6 had both antibodies present (24%) and one mother was ICA positive (4%). 9 of the brothers and sisters of the diabetic patients had high levels of GADA and 2 had both antibodies present. To the first-degree relatives with autoantibodies must be determined other plasma markers too (IAA, IA-2A) as well as genetic markers (HLA typing). CONCLUSIONS The use of plasma markers is recommended as a first step in discovering the relatives with potential risk of developing the disease.

UI MeSH Term Description Entries
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D005260 Female Females
D005968 Glutamate Decarboxylase A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15. Glutamate Carboxy-Lyase,Glutamic Acid Decarboxylase,Acid Decarboxylase, Glutamic,Carboxy-Lyase, Glutamate,Decarboxylase, Glutamate,Decarboxylase, Glutamic Acid,Glutamate Carboxy Lyase

Related Publications

Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
June 2007, Annales d'endocrinologie,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
April 2002, Annals of the New York Academy of Sciences,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
January 2004, The British journal of dermatology,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
April 2003, Diabetes care,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
December 2015, Immunity, inflammation and disease,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
January 2014, Endokrynologia Polska,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
November 2000, Immunology letters,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
January 2003, Przeglad lekarski,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
March 2012, Journal of the neurological sciences,
Adriana Cosmescu, and Mariana Graur, and Mihaela Zlei, and Silvia Mătăsaru, and Doina Felea, and Antoneta Petroaie, and Ana Maria Slanină, and Liliana Barbacariu, and Otilia Momanu
January 2021, Frontiers in immunology,
Copied contents to your clipboard!